increased adrenal gland tumor incidence_Inha<tm1Bay>/Inha<tm1Bay>

http://metadb.riken.jp/0002031I129S7SvEvBrdC57BL6Inhatm1BayInhatm1BayInhatm1Bay

increased adrenal gland tumor incidence_Inha<tm1Bay>/Inha<tm1Bay>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• inhibin alpha
  http://metadb.riken.jp/db/mgi_rdf/MGI:96569

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Inha<tm1Bay>/Inha<tm1Bay>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Inha<tm1Bay>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129S7/SvEvBrd * C57BL/6

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased adrenal gland tumor incidence
  http://purl.obolibrary.org/obo/MP_0002031

文献

http://purl.org/net/cito/citesAsAuthority

• M M. Matzuk, et.al., Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice., Proceedings of the National Academy of Sciences of the United States of America, 1994, 91
  http://rdf.ncbi.nlm.nih.gov/pubmed/8090730
• Brendan D. Looyenga, et.al., Genetic removal of Smad3 from inhibin-null mice attenuates tumor progression by uncoupling extracellular mitogenic signals from the cell cycle machinery., Molecular endocrinology (Baltimore, Md.), 2007, 21
  http://rdf.ncbi.nlm.nih.gov/pubmed/17652186